GeoVax Labs shares are trading higher after EF Hutton initiated coverage on the stock with a Buy rating and announced an $18 price target.
Portfolio Pulse from Benzinga Newsdesk
GeoVax Labs shares are trading higher after EF Hutton initiated coverage on the stock with a Buy rating and announced an $18 price target.
July 23, 2024 | 11:50 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GeoVax Labs shares are experiencing a positive price movement following EF Hutton's initiation of coverage with a Buy rating and an $18 price target.
The initiation of coverage by a reputable firm like EF Hutton with a Buy rating and a specific price target of $18 is likely to boost investor confidence and drive short-term price appreciation for GeoVax Labs.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100